Amalgamated Financial’s Silicon Laboratories SLAB Stock Holding History

Amalgamated Financial’s Portfolio SLAB Stock Details SLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$3.9M	Buy	+25,979	New	+$4.15M	0.03%	598

Other funds holding SLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Amalgamated Financial's SLAB Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Silicon Laboratories (SLAB) in Q1 2022: 25,979 shares worth $3.9M. The stake represents 0.03% of the portfolio and ranks #598 among its holdings.

327 funds tracked by Wall St. Rank hold SLAB as of Q1 2022.

Amalgamated Financial held 25,979 shares of Silicon Laboratories worth $3.9M as of Q1 2022.
Silicon Laboratories was a new Amalgamated Financial position in Q1 2022.
Silicon Laboratories made up 0.03% of Amalgamated Financial's portfolio in Q1 2022, its #598 holding.
327 funds tracked by Wall St. Rank held Silicon Laboratories as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.